Kelkheim, Germany

Rainer Schmiedel

This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rainer Schmiedel. Retrieved from https://idiyas.com/inventor/rainer-schmiedel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rainer Schmiedel: Innovator in Cyclic Peptides

Introduction

Rainer Schmiedel is a notable inventor based in Kelkheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the area of peptide absorption.

Latest Patents

Schmiedel holds a patent for "Cyclic peptides as promoters of absorption on administration onto the mucosa." This invention relates to the use of aids of a specific general formula, which includes various amino acids designed to enhance the absorption of peptides and proteins when administered. The patent emphasizes the importance of these aids in pharmaceutical compositions that contain effective amounts of peptides or proteins.

Career Highlights

Rainer Schmiedel has been associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work has focused on developing innovative solutions that improve drug delivery and efficacy.

Collaborations

Throughout his career, Schmiedel has collaborated with esteemed colleagues such as Jurgen K Sandow and Klaus Wirth. These partnerships have contributed to the advancement of research in peptide absorption and related fields.

Conclusion

Rainer Schmiedel's contributions to the field of cyclic peptides and his innovative patent highlight his role as a key figure in pharmaceutical advancements. His work continues to influence the development of effective drug delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…